Revisiting Querleu-Morrow Radical Hysterectomy: How to Apply the Anatomy of Parametrium and Pelvic Autonomic Nerves to Cervical Cancer Surgery?

Querleu and Morrow classification cervical cancer surgery nerve-sparing hysterectomy parametrium radical hysterectomy surgical anatomy

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
31 Jul 2024
Historique:
received: 01 07 2024
revised: 27 07 2024
accepted: 29 07 2024
medline: 10 8 2024
pubmed: 10 8 2024
entrez: 10 8 2024
Statut: epublish

Résumé

In 2008, Querleu and Morrow proposed a novel classification of radical hysterectomy, which was quickly accepted by the professional oncogynecological community. The Querleu and Morrow (Q-M) classification of radical hysterectomy has provided a unique opportunity for uniform surgical and anatomical terminology. The classification offers detailed explanations of anatomical landmarks and resection margins for the three parametria of the uterus. However, there are still some disagreements and misconceptions regarding the terminology and anatomical landmarks of the Q-M classification. This article aims to highlight the surgical anatomy of all radical hysterectomy types within the Q-M classification. It discusses and illustrates the importance of anatomical landmarks for defining resection margins of the Q-M classification and reviews the differences between Q-M and other radical hysterectomy classifications. Additionally, we propose an update of the Q-M classification, which includes the implementation of parauterine lymphovascular tissue, paracervical lymph node dissection, and Selective-Systematic Nerve-Sparing type C2 radical hysterectomy. Type D was modified according to current guidelines for the management of patients with cervical cancer. The detailed explanation of the surgical anatomy of radical hysterectomy and the proposed update may help achieve surgical harmonization and precise standardization among oncogynecologists, which can further facilitate accurate and comparable results of multi-institutional surgical clinical trials.

Identifiants

pubmed: 39123457
pii: cancers16152729
doi: 10.3390/cancers16152729
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Stoyan Kostov (S)

Research Institute, Medical University Pleven, 5800 Pleven, Bulgaria.
Department of Gynecology, Hospital "Saint Anna", Medical University "Prof. Dr. Paraskev Stoyanov", 9002 Varna, Bulgaria.

Yavor Kornovski (Y)

Department of Gynecology, Hospital "Saint Anna", Medical University "Prof. Dr. Paraskev Stoyanov", 9002 Varna, Bulgaria.

Rafał Watrowski (R)

Department of Obstetrics and Gynecology, Helios Hospital Müllheim, 79379 Müllheim, Germany.
Faculty Associate, Medical Center, University of Freiburg, 79106 Freiburg, Germany.

Angel Yordanov (A)

Department of Gynecologic Oncology, Medical University Pleven, 5800 Pleven, Bulgaria.

Stanislav Slavchev (S)

Department of Gynecology, Hospital "Saint Anna", Medical University "Prof. Dr. Paraskev Stoyanov", 9002 Varna, Bulgaria.

Yonka Ivanova (Y)

Department of Gynecology, Hospital "Saint Anna", Medical University "Prof. Dr. Paraskev Stoyanov", 9002 Varna, Bulgaria.

Hakan Yalcin (H)

Department of Gynecologic Oncology, Ankara Bilkent City Hospital, Maternity Hospital, 06800 Ankara, Turkey.

Ivan Ivanov (I)

Department of General and Clinical Pathology, University Hospital "Dr. Georgi Stranski", 5800 Pleven, Bulgaria.

Ilker Selcuk (I)

Department of Gynecologic Oncology, Ankara Bilkent City Hospital, Maternity Hospital, 06800 Ankara, Turkey.

Classifications MeSH